Effect of superparamagnetic iron oxide on bone marrow

European Radiology

Volumn 10, Issue 9, 2000, Pages 1495-1500

  Hundt, W ^a   Petsch, R ^b   Helmberger, T ^a   Reiser, M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b SIEMENS AG   (Germany)

Author keywords

Bone marrow; Contrast enhancement; Contrast media; Iron; Liver; MR imaging

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIGNAL NOISE RATIO; SPINE RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; CONTRAST MEDIA; HUMANS; IRON; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MUSCLE, SKELETAL; OXIDES; SPINE;

EID: 0033864025     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003300000350     Document Type: Article

References (28)

1. Detection of hepatic metastases: Comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging
2. Hepatic micrometastasis in the rats: Ferrite enhanced MR imaging
3. Superparamagnetic iron oxide: Clinical application as a contrast agent for MR imaging of the liver
4. Iron oxide-enhanced MR imaging of the liver and spleen: Review of the first 5 years
5. Superparamagnetic iron oxide: Clinical time-response study
6. Ferrite particles: A superparamagnetic MR contrast agent for the reticuloendothelial system
7. Superparamagnetic iron oxide: Pharmacokinetics and toxicity
8. Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide
9. Asialoglycoprotein receptor function in benign liver disease: Evaluation with MR imaging
10. Liver tumors in cirrhosis: Experimental study with SPIO-enhanced MR imaging
11. MR imaging enhancement with superparamagnetic iron oxide in chronic liver disease: Influence of liver dysfunction and parenchymal pathology
12. Haematological abnormalities in liver disease
13. The morphology of cirrhosis
14. Breathhold imaging of the upper abdomen using a circular polarized-array coil: Comparison with standard body coil imaging
15. Bone marrow: Ultrasmall superparamagnetic iron oxide for MR imaging
16. Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles
17. Contrast agents for magnetic resonance imaging
18. Gegenwartiger Stand der klinischen Entwicklung von MR-Kontrastmitteln
19. Endocytosis, transfer tubules and lysosomal activity in myeloid sinusal endothelium
20. Uptake of carbone and polystyrene particles by sinusoidal endothelium of rabbit bone marrow and liver and rat bone marrow, with special reference to multiparticle pinocytosis
21. Ultrasmall superparamagnetic iron oxide (USPIO): Characterization of a new class of MR contrast agents
22. Superparamagnetic iron oxide-enhanced MR imaging: Pulse sequence optimization for detection of liver cancer
23. Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis
24. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis
25. Phagocytic capacity of reticuloendothelial system in alcohol
26. Hematologic complications of alcohol abuse
27. Infections in liver disease